This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
IBCN 2024
ESMO 2024
BCAN TT 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Conference Highlights
AUA 2018
AUA 2018
Prostate Cancer
Bladder Cancer
Renal Cancer
Testis & Penile Cancers
Lower Urinary Tract Conditions – Nocturia
GU Reconstruction
Infections & Inflammation
Laparoscopic – Robotic Surgery
Sexual Function
Stone Disease
Press Releases
AUA 2018 Prostate Cancer
Viewing 15-34 of 109 articles
AUA 2018: Prostate Biopsy Centralization at High Volume, Tertiary Care Centers Represents the Most Refined Diagnostic Tool for Prostate Cancer Patients
AUA 2018: The German Risk-Adapted Prostate Cancer Screening Trial (PROBASE) – First Results After Recruitment of 30,000 Men
AUA 2018: The Association Between Physician Trust and Prostate Specific Antigen Screening: Implications for Shared Decision Making
AUA 2018: PROSPER Study Results: Impact of Enzalutamide on Pain and Health-Related Quality of Life in Men with nmCRCP
AUA 2018: Cardiovascular Events and Biomarkers in a Randomized Trial Comparing LHRH Agonist and Antagonist Among Patients with Advanced Prostate Cancer
AUA 2018: The Effectiveness and Safety of Cabazitaxel in Patients with mCRPC in Routine Clinical Practice: Results of CAPRISTANA
AUA 2018: Multicentric Prospective Local Treatment of Metastatic Prostate Cancer (LoMP) Trial
AUA 2018: Which Patients Should Be Still Considered for Late Salvage Radiotherapy for Rising or Persistently Elevated PSA after Radical Prostatectomy?
AUA 2018: The Prevalence and Biopsychosocial Predictors of Suicidality in Men with Prostate Cancer
AUA 2018: Assessing the 20-Year Outcomes of Lymph Node Positive Prostate Cancer Patients: A Plea For Lifelong Follow-Up
AUA 2018: Is Fatal Family History in Prostate Cancer a Predictor of Radical Prostatectomy Outcomes?
AUA 2018: Association Between Environmental Quality and Prostate Cancer Stage at Diagnosis
AUA 2018: Oncological Outcomes of Salvage Radical Prostatectomy in a Contemporary, Multicentre Series of 395 Cases
AUA 2018: Non-Alcoholic Fatty Liver Disease in Men Undergoing ADT for Prostate Cancer
AUA 2018: Quality of Life After Surgery for Localized Prostate Cancer
AUA 2018: Adjuvant and Salvage Radiation Therapy After Radical Prostatectomy and the Impact on Long-Term Outcomes
AUA 2018: Utilization of Salvage Radiation Therapy for Biochemical Recurrence After Radical Prostatectom
AUA 2018: Oncologic Outcomes in Men with High Risk Prostate Cancer Eligible for Both Radical Prostatectomy and Radiotherapy: MD Anderson Multidisciplinary Clinic Experience
AUA 2018: Risk of Secondary Bladder Cancer After High Dose Rate Brachytherapy for Prostate Cancer
AUA 2018: Impact of Perceived Ambiguity and Other Psychological Factors on Previous Prostate Cancer Screening Behavior Among 45-year-old Men: Findings from the PROBASE-Study
1
2
3
4
5
6
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free